相关实验视频
Updated: Jun 24, 2026

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
一种装有人工酶的免疫调节剂阻断了血小板介导乳腺癌的血液转移
Ben Hu1, Huimin Lin1, Xiaolong Quan1
1NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
这项研究介绍了GSNO@B,一种针对血小板媒介转移的纳米酶药物. 它抑制瘤细胞聚合,促进免疫清除,有效抑制瘤生长和转移.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症研究 癌症研究
背景情况:
- 在循环瘤细胞 (CTC) 上的血小板激活有助于生存和转移.
- 微型血栓保护CTC免受免疫监测,促进血源性传播.
- 针对血小板媒介转移对于癌症治疗至关重要.
研究的目的:
- 设计一种纳米酶药物 (GSNO@B),以抑制血小板介导的瘤转移.
- 为了利用葡萄糖氧化酶 (GOx) 和氧化 (NO) 供体产生抗转移效应.
- 使用免疫检查点抑制剂 (BMS-202) 增强CTC清除.
主要方法:
- 开发了一种自组装的纳米酶药物GSNO@B,它结合了GOx,NO供体和BMS-202.
- 利用GOx消耗葡萄糖,抑制血小板活动和微积聚.
- 在现场使用NO释放以减少血小板粘附并暴露CTC.
- 集成的BMS-202释放用于CTCs的免疫清除.
主要成果:
- GSNO@B有效地抑制了CTCs上的血小板活性和微聚合.
- 在现场NO释放减少了CTC-血小板粘附,增强了免疫识别.
- BMS-202释放促进了CTCs的免疫清除.
- 这三步策略抑制了原发性瘤生长和转移的形成.
结论:
- GSNO@B是一种新型纳米酶药物,有效对抗血小板介导的瘤转移.
- 葡萄糖消耗和NO释放的双重作用针对关键的转移性途径.
- 结合免疫检查点抑制剂的联合治疗增强了抗转移疗效.
- 这种方法为阻止血液瘤转移提供了一个有希望的策略.
更多相关视频
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
相关概念视频
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy